Chewy, Inc. CFO David Reeder Discusses Company Growth, Strategic Initiatives, and Future Outlook at JPMorgan Global Technology, Media and Communications Conference
Key Takeaways
TL;DR: Chewy (CHWY) reaffirms low SD active customer growth and +80bps adj. EBITDA margin expansion (to 5.5%) in FY25, driven by healthcare verticals (+1,000bps GM), vet clinic expansion (8–10 new clinics), automation (30%↑ fulfillment productivity), and a path to 10% LT EBITDA margins. $950M FY24 buybacks highlight robust FCF conversion (80% of EBITDA). Key focus: healthcare (30% of sales), Chewy+ membership (early traction), and tariff impacts ($10M EPS headwind).
1. Profitability & Margins
- Adj. EBITDA margins guided to 5.5% (+80bps YoY), with ~60% driven by:
- Healthcare vertical (30% of sales): ~1,000bps GM lift vs. retail.
- Sponsored ads (1% of sales → LT 2–3% target): New 1P ad stack supports off-site/dynamic content.
- Fulfillment automation: 2G centers yield +30% output/sq. ft. Network ~75% utilized.
- OpEx leverage via AI/automation in customer targeting, SKU mgmt., and supplier onboarding.
2. Growth Drivers
- Active customers: +low SD in FY25 (vs. flat pet households). Driven by:
- Vet clinics: 50%+ of clinic customers (inc. ~50% new) order online within 30 days.
- Personalized targeting: AI-driven reactivation/churn reduction (rebuilt 1P tech stack).
- NSPAC (~$578 in ’24): +mid-SD via cross-sell (20% adoption in pharmacy vs. 85% in consumables).
3. Healthcare & Vet Ecosystem
- Pharmacy: >$1B biz growing “significantly faster” than core (compounding, DC-linked fulfillment).
- Vet clinics (8 today → 8–10 new in ’25): Aim to exceed industry avg. unit economics ($2M rev./clinic, 20% EBITDA margin).
4. Capital Allocation
- $525M FCF guided for FY25 (80% EBITDA conversion).
- $950M shares repurchased in FY24 (BC Partners sell-down). Continued buybacks prioritized.
5. Macro & Risks
- Recession resilience: 85% rev. from non-discretionary (food, health).
- Tariffs: $10M EPS drag (hard goods/private brands; mitigated by inventory mgmt).